Publications by authors named "P Jarcuska"
Objective: This study aims to describe the outcomes of COVID-19 patients treated with molnupiravir and to explore the associations with various risk factors.
Methods: We conducted a single-centre, descriptive, retrospective study without a comparison group.
Results: Out of 141 patients, 70 (49.
Background: The Slovak Republic, an Eastern European country, borders Ukraine, which has one of the highest rates of HIV/AIDS in Europe. This study aims to inform readers about the demographic characteristics of Ukrainian war refugees with HIV/AIDS seeking temporary protection status in Slovakia due to the Russian invasion of February 24, 2022. It focuses on their epidemiology, immunological profiles, co-infections, and treatment.
View Article and Find Full Text PDFArticle Synopsis
- The SARS-CoV-2 pandemic has resulted in over 7 million deaths globally, mainly due to viral pneumonia, highlighting the need to identify risk factors for mortality to enable early patient intervention.
- A retrospective study of 299 patients with PCR-confirmed COVID-19 pneumonia in Slovakia identified key risk factors for increased mortality, including age over 60, specific lymphocyte counts, and elevated inflammatory markers.
- The findings confirm that these identified risk factors are significantly linked to patient deaths from viral pneumonia, underscoring their importance in clinical settings.
Introduction: HBeAg-negative chronic HBV infection is defined by viremia < 2,000 IU/ml (or < 20,000 IU/ml), normal ALT activity and minimal liver fibrosis. Some patients do not meet all the criteria and belong to the so-called grey zone. The aim of the work was to analyse a group of patients with asymptomatic chronic HBV infection, divide them according to the levels of HBV DNA during follow-up and to compare the clinical and laboratory parameters of the patients within the groups.
View Article and Find Full Text PDF